Burleson, TX, United States of America

Thomas Yorio

This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Yorio. Retrieved from https://idiyas.com/inventor/thomas-yorio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Yorio: Innovator in Pharmaceutical Compositions

Introduction

Thomas Yorio is a notable inventor based in Burleson, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize pseudoephedrine.

Latest Patents

Yorio holds a patent for his invention titled "(−)-Pseudoephedrine as a sympathomimetic drug." This patent provides pharmaceutical compositions that include (−)-pseudoephedrine and a pharmaceutically acceptable carrier. The invention ensures that the (−)-pseudoephedrine is substantially free of (+)-pseudoephedrine. Additionally, it outlines methods for relieving nasal and bronchial congestion and inducing pupil dilation through the administration of a pharmaceutically effective amount of (−)-pseudoephedrine, which is also free of the side effects associated with (+)-pseudoephedrine.

Career Highlights

Thomas Yorio is associated with Warner-Lambert Company, where he has been able to apply his innovative ideas in a professional setting. His work has contributed to advancements in pharmaceutical formulations and therapeutic methods.

Collaborations

Yorio has collaborated with notable coworkers such as James L Caffrey and Peter Raven, enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Thomas Yorio's contributions to the pharmaceutical industry, particularly through his patent on (−)-pseudoephedrine, highlight his role as an innovator in the field. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…